Prudential Financial’s GSK GSK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-69,272
Closed -$2.83M 2442
2024
Q3
$2.83M Sell
69,272
-4,227
-6% -$173K ﹤0.01% 1278
2024
Q2
$2.83M Buy
73,499
+15,325
+26% +$645K ﹤0.01% 1221
2024
Q1
$2.49M Buy
58,174
+8,117
+16% +$335K ﹤0.01% 1315
2023
Q4
$1.86M Buy
50,057
+24,578
+96% +$882K ﹤0.01% 1481
2023
Q3
$924K Sell
25,479
-672
-3% -$23.9K ﹤0.01% 1806
2023
Q2
$932K Buy
26,151
+9,269
+55% +$332K ﹤0.01% 1839
2023
Q1
$601K Buy
16,882
+6,517
+63% +$228K ﹤0.01% 1986
2022
Q4
$364K Sell
10,365
-8,409
-45% -$280K ﹤0.01% 2161
2022
Q3
$551K Buy
18,774
+2,328
+14% +$88.2K ﹤0.01% 2029
2022
Q2
$900K Buy
16,446
+4,605
+39% +$254K ﹤0.01% 1844
2022
Q1
$645K Buy
11,841
+6,746
+132% +$366K ﹤0.01% 2083
2021
Q4
$274K Buy
+5,095
New +$265K ﹤0.01% 2439
2020
Q4
Sell
-7,320
Closed -$344K 2478
2020
Q3
$344K Buy
7,320
+2,271
+45% +$114K ﹤0.01% 2107
2020
Q2
$257K Buy
5,049
+129
+3% +$6.62K ﹤0.01% 2166
2020
Q1
$233K Buy
4,920
+462
+10% +$24.6K ﹤0.01% 2142
2019
Q4
$262K Buy
+4,458
New +$248K ﹤0.01% 2253

Other funds holding GSK

Prudential Financial's GSK Position: Q4 2024 in Review

Prudential Financial sold out of GSK (GSK) in Q4 2024, closing a stake of 69,272 shares — an estimated $2.83M sold.

Prudential Financial first reported a position in GSK in Q4 2019 and held it in 16 quarters. The position peaked at $2.83M in Q3 2024. 848 funds tracked by Wall St. Rank hold GSK as of Q4 2024.

  • Prudential Financial reported no remaining GSK position as of Q4 2024 after selling out during the quarter.
  • Prudential Financial sold 69,272 GSK shares in Q4 2024, an estimated $2.83M.
  • Prudential Financial first reported a position in GSK in Q4 2019 and held it in 16 quarters.
  • Prudential Financial's GSK position peaked at $2.83M in Q3 2024.
  • 848 funds tracked by Wall St. Rank held GSK as of Q4 2024.

Based on Prudential Financial's 13F filing for Q4 2024, filed 11 Feb 2025.